Navigation Links
Drug Zoloft May Prevent Recurring Depression In Diabetics

According to a new study, the antidepressant drug Zoloft (sertraline) may avoid in preventing recurring of depression in diabetics and may also increase// the time interval between the depressive episodes.

One in every four diabetics experiences depression, according to background information in the study, reports foodconsumer.org.

Researchers studied 152 diabetics, averaging about 53 years of age, who had recovered from depression during treatment with Zoloft -- 79 of the patients were randomly assigned to receive Zoloft and 73 were given a placebo. The patients were tracked for a year or until their depression recurred.

After one year, just under 66 percent of the patients taking Zoloft remained in remission from depression, compared with about 48 percent of patients taking placebo. The amount of time that passed before depression recurred in one-third of the patients increased from 57 days among those taking placebo to 226 days among the patients taking the drug.

The study was funded by drug maker Pfizer Inc., which makes Zoloft, and the U.S. National Institutes of Health.

"Our study establishes a clear benefit of sertraline for prevention of depression recurrence in patients with diabetes," the study authors wrote.

"Sertraline lengthened the depression-free interval of maintenance and did not interfere with glycemic improvement achieved during the recovery phase. Treatment with sertraline is relatively simple, safe and widely available, and although it is not curative, it offers patients with diabetes a potentially viable method for ameliorating the suffering, incapacity and burden associated with recurrent depression," the authors concluded.

Zoloft is one of the selective serotonin reuptake inhibitor (SSRI) class of antidepressants, which also includes brands such as Celexa, Paxil and Prozac.


'"/>




Page: 1

Related medicine news :

1. Lose stomach for Life....Preventive removal of stomach saves the risk of cancer
2. Prevention is better than cure
3. Prevention of cataracts
4. Medications to Prevent Relapse to Cocaine Use
5. Estrogen Does Not Prevent Recurrent Strokes
6. Over-The-Counter Drugs May Prevent Alzheimers
7. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
8. Alcoholism Drug Fails To Prevent Drinking Relapses
9. Preventing mental decline in the aged
10. Preventing white coat hypertension
11. Simple Stroke Prevention is Best
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug Zoloft May Prevent Recurring Depression Diabetics

(Date:9/3/2014)... Diego, CA (PRWEB) September 03, 2014 AttorneyOne.com, ... all the latest information from the FDA on Pedigree ... on August 26, that 22 bags of Pedigree Adult Complete ... to the possible presence of a foreign material. The reason ... metal fragments, which could have entered the packages during the ...
(Date:9/3/2014)... While the Affordable Care Act provides ... the goal of offering better quality care at ... increasing scrutiny of hospital-physician transactions to ensure they ... This increased scrutiny resulted in the first-ever antitrust ... physician practice earlier this year. , ...
(Date:9/3/2014)... LabRoots announces a new educational webinar ... in Translational Diagnostics: Mining and Migrating Robust Cancer ... be airing live September 10, 2014 1:00pm Eastern Time. ... NGS-based biomarker discovery will be introduced, as ... these markers to targeted NGS assays using low-quality (FFPE) ...
(Date:9/3/2014)... (PRWEB) September 03, 2014 Health ... increases patient safety, decreases medical errors, and strengthens ... , To mark the important role health information ... IHS and others across the U.S. have joined ... Week , September 16-20, 2014. With the NHIT ...
(Date:9/3/2014)... 03, 2014 Job seekers who are ... next position can now do both on iHire. By ... a seamless tool for investigating employment and educational opportunities ... online courses) are closing skills gaps and challenging the ... degree programs and brick and mortar universities. To make ...
Breaking Medicine News(10 mins):Health News:Pedigree Adult Complete Nutrition for Dogs Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Recent Becker’s Article Addresses Antitrust and Hospital Acquisition of Physician Practices 2Health News:LabRoots Announces New Educational Webinar on Next-Generation Sequencing 2Health News:LabRoots Announces New Educational Webinar on Next-Generation Sequencing 3Health News:Innovative Healthcare Solutions (IHS) Celebrates National Health IT Week September, 15-19, 2014 2Health News:iHire Announces Partnership with MOOCtracks 2
... Clinical Oncology (ASCO) today highlighted several studies in a ... posted online at www.asco.org in advance of ASCO,s 47th ... other major studies will be released in on-site press ... meeting, which is expected to draw approximately 30,000 cancer ...
... receives the Green Mark Platinum Award from the Building ... environmental sustainability. The highest award presented to selected organisations ... towards sustainability. The award goes to NTU,s School ... piece in the centre of the 200-hectare green campus ...
... , WEDNESDAY, May 18 (HealthDay News) -- New research finds ... cancer don,t reduce the average woman,s risk of dying from ... then a transvaginal ultrasound might even cause harm, the University ... of worrisome false-positive results, subsequent biopsies and resulting complications. ...
... of Pittsburgh School of Medicine have developed a mouse model ... rare genetic mutation that appears to cause MDD in the ... published online today in the American Journal of Medical ... clarify the brain events that lead to MDD, and contribute ...
... Reporter , WEDNESDAY, May 18 (HealthDay News) -- The ... the progression of eye problems in people with the ... says. Italian researchers report that they compared daily ... a placebo, and found that selenium could benefit people ...
... 18 (HealthDay News) -- The results of a first prostate-specific antigen ... can predict the risk of dying of prostate cancer within the ... Researchers analyzed blood samples collected from 12,090 Swedish men between 1974 ... nearly 5,000 of the men six years later when they were ...
Cached Medicine News:Health News:ASCO releases studies from upcoming annual meeting 2Health News:ASCO releases studies from upcoming annual meeting 3Health News:NTU wins Platinum Award from BCA for sustainable design 2Health News:Study Finds Ovarian Screening Tests Don't Improve Survival 2Health News:Pitt researchers build a better mouse model to study depression 2Health News:Selenium Might Help Treat Symptoms in Graves' Eye Disease 2Health News:Selenium Might Help Treat Symptoms in Graves' Eye Disease 3Health News:Earlier PSA Test Best Predicts Risk of Dying From Prostate Cancer: Study 2
(Date:9/3/2014)... ,    ... ~   Kiadis Pharma B.V. ... biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, ... , MD PhD, as its Chief Medical Officer. ... at Ceronco Biosciences. Prior to that he was VP ...
(Date:9/2/2014)... 2014 Reportbuyer.com has added a new ... Technologies for Molecular Imaging Devices ... The objectives of this study are to ... used for diagnostic purposes, present global market measurements ... market segments as well as forecast market and ...
(Date:9/2/2014)... -- Numotion is pleased to announce the appointment of Mark ... Mark is a 30-year retired veteran of GE where ... and was a GE Company Officer since 1999 and a ... running business units within GE Healthcare, with the most recent ... "We are delighted to welcome Mark to our Board," ...
Breaking Medicine Technology:Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 2Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 3Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 5Global Markets and Technologies for Molecular Imaging Devices 2Global Markets and Technologies for Molecular Imaging Devices 3Global Markets and Technologies for Molecular Imaging Devices 4Global Markets and Technologies for Molecular Imaging Devices 5Global Markets and Technologies for Molecular Imaging Devices 6Global Markets and Technologies for Molecular Imaging Devices 7Global Markets and Technologies for Molecular Imaging Devices 8Global Markets and Technologies for Molecular Imaging Devices 9Global Markets and Technologies for Molecular Imaging Devices 10Global Markets and Technologies for Molecular Imaging Devices 11Global Markets and Technologies for Molecular Imaging Devices 12Global Markets and Technologies for Molecular Imaging Devices 13Global Markets and Technologies for Molecular Imaging Devices 14Global Markets and Technologies for Molecular Imaging Devices 15Global Markets and Technologies for Molecular Imaging Devices 16Global Markets and Technologies for Molecular Imaging Devices 17Global Markets and Technologies for Molecular Imaging Devices 18Global Markets and Technologies for Molecular Imaging Devices 19Global Markets and Technologies for Molecular Imaging Devices 20Global Markets and Technologies for Molecular Imaging Devices 21Global Markets and Technologies for Molecular Imaging Devices 22Global Markets and Technologies for Molecular Imaging Devices 23Global Markets and Technologies for Molecular Imaging Devices 24Global Markets and Technologies for Molecular Imaging Devices 25
... Tenn., Nov. 18, 2011 MedSolutions , ... services, today announced the launch of its Implantable ... evidence-based guidelines to ensure the clinical appropriateness of ... With the cost of each ICD/CRT-D ...
... Md., Nov. 18, 2011 The U.S. Food and ... ) to treat patients with acute lymphoblastic leukemia (ALL), ... coli derived asparaginase and pegaspargase chemotherapy drugs used ... ) Acute lymphoblastic leukemia is a ...
Cached Medicine Technology:MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 2MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 3FDA Approves Erwinaze to Treat a Form of Leukemia 2FDA Approves Erwinaze to Treat a Form of Leukemia 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: